Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | PAR 21 097

Opportunity Information: Apply for PAR 21 097

The National Institutes of Health (NIH) funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)" (Funding Opportunity Number PAR-21-097; CFDA 93.273) is a discretionary grant program designed to support early-stage, planning-focused research on fetal alcohol spectrum disorders (FASD). The central purpose is to help investigators build the scientific and practical groundwork needed before launching larger, full-scale prevention or intervention trials. In other words, the R34 mechanism here is meant to fund the kinds of preparatory studies that reduce risk and uncertainty for a later, bigger project, such as refining an intervention, testing feasibility, establishing recruitment pipelines, validating outcome measures, or developing protocols and implementation plans that are strong enough to compete for and successfully run a subsequent large study.

The FOA prioritizes two broad and complementary research directions across the full lifespan. First, it supports prevention approaches that aim to reduce prenatal alcohol exposure and ultimately decrease the incidence of FASD. This can include work that identifies effective strategies to prevent alcohol use during pregnancy, improves screening and brief intervention models, strengthens referral and treatment linkages, or addresses social, behavioral, clinical, and structural drivers of prenatal alcohol exposure. Second, it supports interventions for individuals with FASD, which can span infancy through adulthood and may target cognitive, behavioral, emotional, physical, educational, social, or functional outcomes. The emphasis is on moving the field forward with practical, evidence-building steps that enable later definitive testing, rather than trying to complete a large efficacy or effectiveness trial within the R34 itself.

A key feature is that the FOA is labeled "Clinical Trial Optional," meaning applicants may propose a clinical trial if it fits the planning-grant purpose, but they are not required to do so. This flexibility allows projects that are strictly preparatory (for example, measure development, formative research, pilot implementation work, feasibility assessments, or small proof-of-concept studies) as well as projects that include a limited clinical trial component when that is the best way to answer a necessary planning question. The expectation remains that the work will directly position the team for a subsequent, larger-scale FASD prevention or intervention application, with clearer protocols, stronger justification for design choices, and stronger evidence that the approach is feasible, acceptable, and measurable.

The announcement also signals an alternative pathway for teams who want a staged, exploratory project structure: applicants interested in an exploratory phased approach can consider the R61/R33 option referenced in the FOA (PAR-21-NNN). That note is essentially guidance that, depending on the maturity of the concept and the desired milestone-driven progression, a different NIH mechanism might be a better fit than the R34 planning grant.

Eligibility is broad and intentionally inclusive, spanning governmental, academic, nonprofit, and private-sector organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding higher education institutions in those categories); for-profit organizations other than small businesses; small businesses; and other categories. The FOA explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This wide eligibility aligns with the real-world nature of FASD prevention and intervention work, which often benefits from clinical-community partnerships, school and service system involvement, and culturally grounded approaches led by or co-developed with affected communities.

From an administrative standpoint, this is an NIH grant opportunity (Funding Instrument: Grant; Activity Category: Health) that was created on 2020-12-11, with an original closing date listed as 2023-10-17 in the provided source data. No award ceiling or expected number of awards is specified in the excerpt you provided, so applicants would typically consult the full FOA text and NIH institute/center guidance for budget and project period expectations typical of the R34 mechanism, as well as any institute-specific priorities related to FASD research.

Overall, the opportunity is best understood as a stepping-stone program: it funds the careful planning, piloting, and optimization work needed to produce a credible, scalable, and fundable next-stage proposal that can more definitively test prevention strategies to reduce prenatal alcohol exposure and FASD incidence, or interventions that improve outcomes for people living with FASD across the lifespan.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
• This funding opportunity was created on 2020-12-11.
• Applicants must submit their applications by 2023-10-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 21 097

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: